Clark Capital Management Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $99.3M | Buy |
|
|||||
|
2025
Q2 | $46.6M | Buy |
|
|||||
|
2025
Q1 | $28.8M | Buy |
|
|||||
|
2024
Q4 | $658K | Buy |
|
|||||
|
2024
Q3 | $414K | Sell |
|
|||||
|
2024
Q2 | $425K | Buy |
|
|||||
|
2024
Q1 | $349K | Sell |
|
|||||
|
2023
Q4 | $375K | Buy |
|
|||||
|
2023
Q3 | $347K | Sell |
|
|||||
|
2023
Q2 | $378K | Sell |
|
|||||
|
2023
Q1 | $386K | Sell |
|
|||||
|
2022
Q4 | $22.8M | Buy |
|
|||||
|
2022
Q3 | $17.8M | Sell |
|
|||||
|
2022
Q2 | $29.9M | Sell |
|
|||||
|
2022
Q1 | $48.2M | Buy |
|
|||||
|
2021
Q4 | $41.3M | Sell |
|
|||||
|
2021
Q3 | $77.6M | Buy |
|
|||||
|
2021
Q2 | $60M | Buy |
|
|||||
|
2021
Q1 | $31.5M | Sell |
|
|||||
|
2020
Q4 | $33.6M | Buy |
|